CITED2 attenuates macrophage recruitment concordant with the downregulation of CCL20 in breast cancer cells

Jayaraman,Swaathi; Doucet,Michele; Kominsky,Scott  L.

doi:10.3892/ol.2017.7420

CITED2 attenuates macrophage recruitment concordant with the downregulation of CCL20 in breast cancer cells

Authors:
- Swaathi Jayaraman
- Michele Doucet
- Scott L. Kominsky
View Affiliations

Affiliations: Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
Published online on: November 15, 2017 https://doi.org/10.3892/ol.2017.7420
Pages: 871-878
Copyright: © Jayaraman et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The transcriptional co‑regulator Cbp/p300‑interacting transactivator with Glu/Asp‑rich carboxy‑terminal domain‑2 (CITED2) may promote breast tumor growth; however, the mechanisms by which its effects are mediated remain to be fully elucidated. Tumor‑associated macrophages serve an important function in tumor development and progression and are recruited by chemotactic factors produced by cells within the tumor microenvironment. The present study assessed the effects of CITED2 silencing on macrophage recruitment in two xenograft mouse models of human breast cancer, one in which tumor growth was sensitive to CITED2 silencing (MDA‑MB‑231) and one in which it was insensitive (MDA‑MB‑468). The present study identified that silencing CITED2 significantly attenuated macrophage infiltration in MDA‑MB‑231 but not MDA‑MB‑468 orthotopic tumors, concordant with its effect on tumor growth. Correspondingly, conditioned media obtained from CITED2‑silenced MDA‑MB‑231 cells exhibited a significantly decreased ability to induce macrophage recruitment by Transwell migration assay, whereas the chemotactic effect of MDA‑MB‑468 conditioned media was unaffected. Examining the expression of macrophage chemoattractants within orthotopic tumors and tumor cell‑conditioned media revealed a significant decrease in C‑C motif chemokine ligand (CCL)20 mRNA and protein expression following CITED2‑silencing in MDA‑MB‑231 cells, compared with that in cells transfected with scramble shRNA. However, mRNA and protein expression was unaffected by CITED2‑silencing in MDA‑MB‑468 cells. Furthermore, chromatin immunoprecipitation analysis revealed that CITED2 was localized to the CCL20 promoter in MDA‑MB‑231 cells, suggesting that it serves a direct function in its regulation, which is consistent with the effect of CITED2 silencing on CCL20 expression. Lastly, neutralizing CCL20 in the conditioned media of MDA‑MB‑231 cells significantly inhibited macrophage recruitment. Collectively, these results suggest that CITED2 is involved in modulating macrophage recruitment, representing a novel mechanism through which it may influence tumor growth. This may be partly mediated by regulating tumor cell production of the chemokine CCL20.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	De Palma M and Lewis CE: Cancer: Macrophages limit chemotherapy. Nature. 472:303–304. 2011. View Article : Google Scholar : PubMed/NCBI
3	Nielsen SR and Schmid MC: Macrophages as key drivers of cancer progression and metastasis. Mediators Inflamm. 2017:96247602017. View Article : Google Scholar : PubMed/NCBI
4	Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78. 2004. View Article : Google Scholar : PubMed/NCBI
5	Ruffell B and Coussens LM: Macrophages and therapeutic resistance in cancer. Cancer Cell. 27:462–472. 2015. View Article : Google Scholar : PubMed/NCBI
6	Zhang QW, Liu L, Gong CY, Shi HS, Zeng YH, Wang XZ, Zhao YW and Wei YQ: Prognostic significance of tumor-associated macrophages in solid tumor: A meta-analysis of the literature. PloS One. 7:e509462012. View Article : Google Scholar : PubMed/NCBI
7	Birbrair A, Zhang T, Wang ZM, Messi ML, Olson JD, Mintz A and Delbono O: Type-2 pericytes participate in normal and tumoral angiogenesis. Am J Physiol Cell Physiol. 307:C25–C38. 2014. View Article : Google Scholar : PubMed/NCBI
8	Shih JY, Yuan A, Jeremy JW and Yang PC: Tumor-associated macrophage: Its role in cancer invasion and metastasis. J Cancer Mol. 101–106. 2006.
9	Frankenberger C, Rabe D, Bainer R, Sankarasharma D, Chada K, Krausz T, Gilad Y, Becker L and Rosner MR: Metastasis suppressors regulate the tumor microenvironment by blocking recruitment of prometastatic tumor-associated macrophages. Cancer Res. 75:4063–4073. 2015. View Article : Google Scholar : PubMed/NCBI
10	Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA and Pollard JW: CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 475:222–225. 2011. View Article : Google Scholar : PubMed/NCBI
11	Green CE, Liu T, Montel V, Hsiao G, Lester RD, Subramaniam S, Gonias SL and Klemke RL: Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization. PloS One. 4:e67132009. View Article : Google Scholar : PubMed/NCBI
12	Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, Graf T, Pollard JW, Segall J and Condeelis J: A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 64:7022–7029. 2004. View Article : Google Scholar : PubMed/NCBI
13	Bhattacharya S, Michels CL, Leung MK, Arany ZP, Kung AL and Livingston DM: Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 13:64–75. 1999. View Article : Google Scholar : PubMed/NCBI
14	Braganca J, Eloranta JJ, Bamforth SD, Ibbitt JC, Hurst HC and Bhattacharya S: Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2. J Biol Chem. 278:16021–16029. 2003. View Article : Google Scholar : PubMed/NCBI
15	Chou YT, Wang H, Chen Y, Danielpour D and Yang YC: Cited2 modulates TGF-beta-mediated upregulation of MMP9. Oncogene. 25:5547–5560. 2006. View Article : Google Scholar : PubMed/NCBI
16	Glenn DJ and Maurer RA: MRG1 binds to the LIM domain of Lhx2 and may function as a coactivator to stimulate glycoprotein hormone alpha-subunit gene expression. J Biol Chem. 274:36159–36167. 1999. View Article : Google Scholar : PubMed/NCBI
17	Lau WM, Doucet M, Huang D, Weber KL and Kominsky SL: CITED2 modulates estrogen receptor transcriptional activity in breast cancer cells. Biochem Biophys Res Commun. 437:261–266. 2013. View Article : Google Scholar : PubMed/NCBI
18	Tien ES, Davis JW and Vanden Heuvel JP: Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator. J Biol Chem. 279:24053–24063. 2004. View Article : Google Scholar : PubMed/NCBI
19	Qu X, Lam E, Doughman YQ, Chen Y, Chou YT, Lam M, Turakhia M, Dunwoodie SL, Watanabe M, Xu B, et al: Cited2, a coactivator of HNF4alpha, is essential for liver development. EMBO J. 26:4445–4456. 2007. View Article : Google Scholar : PubMed/NCBI
20	Xu B, Qu X, Gu S, Doughman YQ, Watanabe M, Dunwoodie SL and Yang YC: Cited2 is required for fetal lung maturation. Dev Biol. 317:95–105. 2008. View Article : Google Scholar : PubMed/NCBI
21	Yin Z, Haynie J, Yang X, Han B, Kiatchoosakun S, Restivo J, Yuan S, Prabhakar NR, Herrup K, Conlon RA, et al: The essential role of Cited2, a negative regulator for HIF-1alpha, in heart development and neurulation. Proc Natl Acad Sci USA. 99:pp. 10488–10493. 2002; View Article : Google Scholar : PubMed/NCBI
22	Bai L and Merchant JL: A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion. FEBS Lett. 581:5904–5910. 2007. View Article : Google Scholar : PubMed/NCBI
23	Chou YT, Hsieh CH, Chiou SH, et al: CITED2 functions as a molecular switch of cytokine-induced proliferation and quiescence. Cell Death Differ. 19:2015–2028. 2012. View Article : Google Scholar : PubMed/NCBI
24	Jayaraman S, Doucet M and Kominsky SL: Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-β-induced expression of VEGFA. Oncotarget. 8:6169–6178. 2017.PubMed/NCBI
25	Jayaraman S, Doucet M, Lau WM and Kominsky SL: CITED2 modulates breast cancer metastatic ability through effects on IKKα. Mol Cancer Res. 14:730–739. 2016. View Article : Google Scholar : PubMed/NCBI
26	Lau WM, Weber KL, Doucet M, Chou YT, Brady K, Kowalski J, Tsai HL, Yang J and Kominsky SL: Identification of prospective factors promoting osteotropism in breast cancer: A potential role for CITED2. Int J Cancer. 126:876–884. 2010.PubMed/NCBI
27	Sun HB, Zhu YX, Yin T, Sledge G and Yang YC: MRG1, the product of a melanocyte-specific gene related gene, is a cytokine-inducible transcription factor with transformation activity. Proc Natl Acad Sci USA. 95:pp. 13555–13560. 1998; View Article : Google Scholar : PubMed/NCBI
28	Chou YT and Yang YC: Post-transcriptional control of Cited2 by transforming growth factor beta. Regulation via Smads and Cited2 coding region. J Biol Chem. 281:18451–18462. 2006. View Article : Google Scholar : PubMed/NCBI
29	National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, . Guide for the Care and Use of Laboratory Animals. 8th. Washington (DC): National Academies Press (US); 2011, ISBN-13. ISBN: 978-0-309-15400-0ISBN-10. ISBN: 0-309-15400-6PubMed/NCBI
30	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantiative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
31	Baay M, Brouwer A, Pauwels P, Peeters M and Lardon F: Tumor cells and tumor-associated macrophages: Secreted proteins as potential targets for therapy. Clin Dev Immunol. 2011:5651872011. View Article : Google Scholar : PubMed/NCBI
32	Bingle L, Lewis CE, Corke KP, Reed MW and Brown NJ: Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer. 94:101–107. 2006. View Article : Google Scholar : PubMed/NCBI
33	Aharinejad S, Paulus P, Sioud M, Hofmann M, Zins K, Schäfer R, Stanley ER and Abraham D: Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res. 64:5378–5384. 2004. View Article : Google Scholar : PubMed/NCBI
34	Beider K, Abraham M, Begin M, Wald H, Weiss ID, Wald O, Pikarsky E, Abramovitch R, Zeira E, Galun E, et al: Interaction between CXCR4 and CCL20 pathways regulates tumor growth. PloS One. 4:e51252009. View Article : Google Scholar : PubMed/NCBI
35	Goswami S, Sahai E, Wyckoff JB, Cammer M, Cox D, Pixley FJ, Stanley ER, Segall JE and Condeelis JS: Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 65:5278–5283. 2005. View Article : Google Scholar : PubMed/NCBI
36	Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, et al: DPC4 gene in various tumor types. Cancer Res. 56:2527–2530. 1996.PubMed/NCBI